In September 2018, the National Pharmaceutical Council partnered with Discern Health to convene a roundtable of expert stakeholders to better understand the current state of patient-reported measurement in oncology and chart a path to a more patient-centered state. Building on the roundtable activities, interviews with subject matter experts, and other research, NPC and Discern are developing a white paper (to be released in early 2019) that will make policy recommendations for improving patient-reported measures in oncology value-based payment programs.
Join us for a webinar, led by roundtable co-chairs Drs. Mark McClellan, Director, Duke-Margolis Center for Health Policy, and Ethan Basch, Director, Cancer Outcomes Research Program, UNC Lineberger Comprehensive Cancer Center, to explore action steps for bringing the patient voice into oncology value-based payment programs.
This webinar will:
- Provide a high-level overview of patient-reported measures in oncology, including current use in programs such as the Oncology Care Model (OCM) and Merit-based Incentive Payment System (MIPS);
- Share findings and policy recommendations from the NPC and Discern Health research; and
- Engage a diverse panel of stakeholders in discussing how to implement patient-reported measures in programs while ensuring appropriate resources are available and measures are meaningful to patients.